Telomere length as a predictor of therapy response and survival in patients diagnosed with ovarian carcinoma.
Tomasova K, Seborova K, Kroupa M, Horak J, Kavec M, Vodickova L, Rob L, Hruda M, Mrhalova M, Bartakova A, Bouda J, Fleischer T, Kristensen VN, Vodicka P, Vaclavikova R.
Tomasova K, et al. Among authors: vaclavikova r.
Heliyon. 2024 Jun 29;10(13):e33525. doi: 10.1016/j.heliyon.2024.e33525. eCollection 2024 Jul 15.
Heliyon. 2024.
PMID: 39050459
Free PMC article.